CHEMORES is an EU funded research collaboration involving clinicians and scientists at 20 universities, organizations for cancer research and research-oriented biotechnology companies in eight European countries. The purpose of the project is to improve cancer treatment by obtaining increased knowledge on mechanisms of chemotherapy resistance.
Cancer represents one of the most serious health problems in Europe. It is estimated that the two diseases that are studied in CHEMORES, lung cancer and melanoma, caused over 350,000 deaths in Europe in 2002. An important contributing factor in cancer mortality is the fact that the most common types of cancer do not respond well to systemic chemotherapy in the advanced stages. Increased understanding of the underlying processes will contribute to the development of predictors of both therapy response and toxicity, and in the end more efficient and personalised therapy.
NEWS
LATEST PUBLICATIONS
"Evaluation and Prognostic Significance of Circulating
Tumor Cells in Patients With Non–Small-Cell Lung Cancer" by Partner 15b at University of Manchester, UK.
"Diagnostic and prognostic role of plasma
levels of two forms of cytokeratin 18 in patients with non-small-cell lung
cancer" by Partner 1 at Karolinska Institutet, Sweden.
"The dendritic cell-tumor cross-talk in cancer" by Partner 3 at INSERM, France.
FOURTH ANNUAL REPORT
The fourth annual report for the CHEMORES project was sent to the EC in March 2011. Click here for a Summary of the report.
WORKSHOPS ON CHEMORESISTANCE
One workshop on chemoresistance will be organised by CHEMORES on September 21-22, 2011 in Stockholm, Sweden. Click here for FINAL Program. 11
European CME credits
are approved by Accreditation
Council of Oncology in Europe (ACOE) and 12 European
Continuing Medical Education Credits (ECMEC) by the European Union of Medical Specialists (UEMS) for
this workshop. Deadline for registration: September 9, 2011. Reserve your seats today!
MEETINGS
The fifth annual CHEMORES meeting is to be held in Munich, Germany on October 13-14, 2011. Click here for First announcement. Deadline for registration: September 16, 2011.
The information given here reflects the author’s view only. The European Community is not liable for any use that may be made of the information.
|
 |
